Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients

Clinical trial NCT01401010 · COMPLETED

Trial details

NCT number: NCT01401010
Sponsor: Gary E. Stein, Pharm.D.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Febrile Neutropenia

Start date: 2010-08-01
Primary completion: 2012-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.